Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Serpin F2/alpha 2-Antiplasmin Antibody, Novus Biologicals™

Goat Polyclonal Antibody has been used in 3 publications
Supplier: Novus Biologicals NB10096916
Description
Serpin F2/alpha 2-Antiplasmin Polyclonal specifically detects Serpin F2/alpha 2-Antiplasmin in Human samples. It is validated for Western Blot, Flow Cytometry, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Paraffin, Peptide ELISA.Specifications
Serpin F2/alpha 2-Antiplasmin | |
Polyclonal | |
Unconjugated | |
Tris saline (20 mM Tris pH 7.3, 150 mM NaCl), 0.5% BSA with 0.02% Sodium Azide | |
AAPclade F (alpha-2 antiplasmin, Alpha-2-AP, Alpha-2-PI, Alpha-2-plasmin inhibitor, pigment epithelium derived factor), member 2, Serpin F2, serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epitheliumderived factor), member 2 | |
Goat | |
Affinity Purified | |
RUO | |
Primary | |
This antibody is expected to recognize both reported isoforms (NP_000925.2; NP_001159393.1). Reported variants represent identical protein (NP_000925.2; NP_001159392.1). | |
Store at -20C. Avoid freeze-thaw cycles. |
Western Blot, Flow Cytometry, Immunohistochemistry, Immunocytochemistry, Immunofluorescence, Immunohistochemistry (Paraffin), ELISA | |
0.5 mg/mL | |
Western Blot 0.3 - 1 ug/mL, Flow Cytometry 10 ug/mL, Immunohistochemistry 3 - 5 ug/mL, Immunocytochemistry/Immunofluorescence 10 ug/mL, Immunohistochemistry-Paraffin 3 - 5 ug/mL, Peptide ELISA Detection limit 1:16000 | |
P08697 | |
SERPINF2 | |
Peptide with sequence C-KDFLQSLKGFPRGDK corresponding to internal region according to NP_000925.2, NP_001159393.1. | |
0.1 mg | |
Cardiovascular Biology | |
5345 | |
Human | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction